REM |
Array Biopharma Inc (NASDAQ:ARRY) attains midstage triumph for asthma …
FinancialsTrend Dallas, Texas 07/24/2013 (Financialstrend) – Array Biopharma Inc (NASDAQ:ARRY) has an additional benefit on deck for a prospective affiliation. The Boulder, CO-based medicine creator has touted upbeat Stage II facts for an experimental medicine in … Biotech News Bundle: BioCryst, NeoStem, Array Biopharma , Lexicon, GTx … Biotech Top Gainers,BioCryst Pharmaceuticals,Array Biopharma,NeoStem … Biotech Stocks Amid Structural And Capital Change: BioCryst Pharmaceuticals … |
View full post on asthma – Google News